December 11, 2018

IntegriChain’s Josh Halpern to Present on Data-Driven Patient Services at CBI Trade & Channel 2018 Conference

Philadelphia, PA, December 12, 2018 – IntegriChain, a leading life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence, today announced that Co-Founder and EVP, Product & Strategy, Josh Halpern, will present at the CBI 2018 Trade & Channel Conference. Halpern’s presentation, “Opportunities for Data-Driven Patient Services,” will be on Wednesday, December 12, at 1:45 pm. The 14th annual CBI Trade & Channel Conference runs December 11 to 12 at the DoubleTree Hilton Center City, Philadelphia.

About IntegriChain
IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. The IntegriChain ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 140 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, and its Access Management Operations center is in Ambler, PA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain andLinkedIn.

Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com